Investor Centre

Board of Directors

sample name

DR PAUL SCHOBER

NON-EXECUTIVE CHAIRMAN

Paul was appointed to the Board in June 2017. His 30- year career in the animal health industry includes senior executive positions in which he established global distribution agreements and implemented commercial rigour for biotechnology research companies including Peptech Animal Health, Anatara Lifesciences and Apex Laboratories. Paul attained PhD and MBA degrees at the University of Sydney.

sample name

MR JIM COOPER

MANAGING DIRECTOR AND CEO

Jim was appointed to the Board and as CEO of the Company in June 2020. Jim’s commercial experience in growing businesses comes from his roles running infrastructure assets (he was CEO at Port of Portland and an executive at Port of Melbourne) and prior to that he was a corporate lawyer. He has focussed on growing sales through business development, the development of clear corporate strategy and driving sustainability. Much of Jim’s career has been focussed on the agriculture industry and dealing with farmers and the supply chain. Jim holds a Bachelor of Economics and a Bachelor of Laws (with Honours) from Monash University, Melbourne.

sample name

MR SAM BROUGHAM

NON-EXECUTIVE DIRECTOR

Sam was appointed Chairman of the Board in July 2017. He has over thirty years’ experience in private and public investment and is currently a director of Ellerston Global Investments and Ceres Capital, a private global equity investment firm he co-founded in 1999. Sam also co-founded Structured Asset Management in 1993. After receiving an economics degree from the University of Adelaide, he spent his early career with Price Waterhouse, and as a partner at JB Were.

sample name

DR GREGORY ROBINSON NON-EXECUTIVE DIRECTOR

NON-EXECUTIVE DIRECTOR

Greg was appointed to the Board in September 2012. He is currently the Chairman and CEO of Exablaze, an Australian manufacturer of the world’s fastest computer networking equipment. Prior to this Greg worked in the Financial Services industry for more than 25 years. He has had exposure to Trading, Funds Management and Stockbroking. He served as Managing Director and CEO of Asia Pacific for ITG, a listed (NYSE:ITG) global quantitative stockbroker. Greg holds BSc (Hons) and PhD degrees in Physics from the University of Melbourne. He became a Member of the ASX in 1997. He is also a Fellow of the Financial Services Institute of Australia and a Member of the Australian Institute of Company Directors. He has undertaken business development in many parts of the globe, and has also managed businesses domiciled in Hong Kong, Singapore, Japan and the US.

sample name

DR JOHN RYALS

NON-EXECUTIVE DIRECTOR

Dr. Ryals was appointed to the Board in December 2019. Dr Ryals has 30 years of experience in the biotechnology industry, including senior research positions at Novartis and Ciba-Geigy. Dr. Ryals served as president and CEO at Metabolon from 2002 until 2018. Before founding Metabolon, he was CEO, president and founder of Paradigm Genetics, Inc., a publicly traded agriculture biotechnology company focused on industrializing the process of gene function discovery. He currently serves on the Board of Directors of AgBiome, a provider of early-stage Research and Development for agriculture, and the advisory board of the College of Agriculture and Life Sciences at North Carolina State University. Dr Ryals has a Bachelor of Arts in biology and chemistry from the University of North Texas and masters and doctorate degrees from the University of Texas at Dallas.

sample name

MS INGRID VAN DIJKEN

NON-EXECUTIVE DIRECTOR

Ingrid was appointed to the Board in December 2019. Ingrid has more than 20 years’ experience in private banking and funds management. She was based in Switzerland for more than twelve years, including eight years at Union Bancaire Privee, at the Geneva headquarters. In Australia, Ingrid managed the UHNW segment of NAB Private Wealth in Victoria for five years before joining the Impact Investment Group (IIG), Melbourne, in early 2014 as General Manager. During her four year tenure at IIG, Ingrid became Chief Operating Officer & Head of Investor Relations and was instrumental in driving the transformation from a start-up to a medium sized funds management business, transacting in excess of $1 billion across commercial real estate, large scale renewable energy infrastructure and venture capital sectors. Ingrid was also a non-executive board member of wealth management firm, Escala Partners, for four years till March 2019. Ingrid currently works at a privately held funds management firm in Melbourne and is Trustee of the St Peters Eastern Hill Melbourne Charitable Foundation. She holds a Masters’ degree in International Relations from the Graduate Institute in Geneva and an undergraduate degree from the Universiteit Utrecht, in the Netherlands.

sample name

MR TRAVIS DILLON

NON-EXECUTIVE DIRECTOR

Travis was appointed to the Board in May 2020. He brings extensive commercial and strategic expertise in the agricultural sector and relevant distribution channels. Travis was the CEO and Managing Director of Ruralco Holdings Limited (“Ruralco”) until its acquisition by Nutrien in September 2019. Prior to becoming Ruralco’s Managing Director in 2015, he was the Executive General Manager of Ruralco’s Operations. Over a career in Agriservices, spanning nearly three decades, Travis has held many positions including Branch Manager, Agronomist and numerous Category Manager roles, experience which will bring relevant insights to the Terragen Board. Travis is a Non-Executive Director of Lifeline Australia.